The US Justice Department filed a lawsuit to block a $570 million deal in the corporate travel market over antitrust concerns ...
Every investor in Silence Therapeutics plc ( NASDAQ:SLN) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 44% to be precise, ...
Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles.
Boost productivity with these essential Microsoft Outlook tips. Learn how to organize your inbox, automate tasks, and ...
Context Therapeutics (NASDAQ:CNTX – Get Free Report) was upgraded by Citizens Jmp to a “strong-buy” rating in a note issued ...
As global markets navigate a mixed start to the new year, with U.S. stocks closing out a robust 2024 despite recent volatility and economic indicators like the Chicago PMI showing contraction, ...
Lung cancer remains one of the deadliest cancers globally. Non-small cell lung cancer (NSCLC), which accounts for 85% of all lung cancer cases, is particularly challenging to treat due to difficulties ...
The United States market has remained flat over the past week but has seen a significant rise of 23% in the last year, with earnings expected to grow by 15% annually in the coming years. In this ...